Tech & Pharma
Celsion and Zhejiang Hisun will continue clinical development of ThermoDox®, a heat-activated liposomal encapsulation of doxorubicin.
Lumenis Ltd. will distribute the Visionix ophthalmic and optometric diagnostics product line in China.
The Serum Institute of India has announced plans to take a promising new tuberculosis vaccine, developed in Germany, into the clinic.
Agilent and Temasek Polytechnic have opened a new laboratory to study the safety and quality standards in traditional Chinese medicine and food products.
Singapore’s Nanyang Technological University and Rolls-Royce have launched a S$75 million research hub called the Rolls-Royce@NTU Corporate Lab.
The University of Queensland spin-off Protagonist Therapeutics, Inc. has completed a US$14 million Series B venture financing initiative.
H. Lundbeck A/S and Otsuka Pharma announced Phase II clinical data on their Lu AE58054 investigational drug for moderate Alzheimer’s disease.
Chinese pharma Luqa Pharmaceuticals will commercialize BMG Pharma’s products in China and Hong Kong.
Kinex Pharma will lead Hanmi Pharma’s Orascovery program development in China.
A Japan-Singapore research collaboration has been set up to develop technologies that can better detect major eye disorders and diseases.